CytoCore, Diamics settle lawsuit

By Elaine Rigoli

Tampa, Fla., April 5 - CytoCore, Inc., formerly Molecular Diagnostics, and Diamics, Inc. have amicably resolved the dispute between them pertaining to allegations of trade secret misappropriation, unfair competition, patent infringement, copyright infringement and other causes of action raised in connection with litigation in Federal District Court in San Francisco, the companies said in a news release.

The case was Civil Action No. C-05-02549 SI.

Chicago-based CytoCore develops systems to assist in the early detection of cervical, endometrial and other cancers.

Novato, Calif.-based Diamics is a molecular-based cancer screening company initially focused on cervical screening.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.